Obesity, diabetes may up dementia risk 10 years earlier in men: Study
New Delhi, Nov 27 (IANS) Men with cardiovascular disease risk factors such as type 2 diabetes, obesity, high blood pressure, and smoking may have brain health decline, leading to dementia, 10 years earlier than women, finds a study on Wednesday. The findings of a long-term study, published online in the Journal of Neurology Neurosurgery &
New Delhi, Nov 27 (IANS) Men with cardiovascular disease risk factors such as type 2 diabetes, obesity, high blood pressure, and smoking may have brain health decline, leading to dementia, 10 years earlier than women, finds a study on Wednesday.
The findings of a long-term study, published online in the Journal of Neurology Neurosurgery & Psychiatry, showed that men with cardiovascular disease risk factors can have dementia onset a decade earlier — from their mid-50s to mid-70s — than similarly affected women who are most susceptible from their mid-60s to mid-70s.
Researchers from Imperial College London, UK found that the most vulnerable regions of the brain are those involved in processing auditory information, aspects of visual perception, emotional processing, and memory. They noted that the damaging effects are just as evident in those who didn’t carry the high-risk APOE4 gene — a genetic risk factor for Alzheimer’s disease — as those who did.
“The detrimental impact of cardiovascular risk was widespread throughout cortical regions, highlighting how cardiovascular risk can impair a range of cognitive functions,” said the researchers.
The study included 34,425 participants from the UK Biobank all of whom had had both abdominal and brain scans. Their average age was 63, but ranged from 45 to 82.
The results showed that both men and women with increased levels of abdominal fat and visceral adipose tissue had lower brain grey matter volume.
High cardiovascular risk and obesity led to a gradual loss of brain volume over several decades, said the researchers.
The team thus stressed the need to target “modifiable cardiovascular risk factors, including obesity,” to treat or prevent neurodegenerative diseases, like Alzheimer’s.
The study also emphasises “the importance of aggressively targeting cardiovascular risk factors before the age of 55 years to prevent neurodegeneration and Alzheimer’s disease”. These may also prevent other cardiovascular events, such as myocardial infarction [heart attack] and stroke”.
While the study is observational and no firm conclusions can be drawn, targeting cardiovascular risk and obesity early may be crucial.
–IANS
rvt/
Odisha Vigilance Arrests College Principal for Taking Bribe
Next ArticleBeguniapada CDPO Arrested while Accepting Bribe from Anganwadi Helper
Related Articles
New AI tool to revolutionise personalised cancer treatment

Health & LifestyleNew AI tool to revolutionise personalised cancer treatment
New Delhi: An international team of scientists has developed an artificial intelligence (AI) tool that could revolutionise cancer treatment by mapping cellular diversity within tumours. The innovation tackles tumour heterogeneity in oncology, where varied cell populations cause treatment resistance and recurrence, Xinhua news agency reported. The AAnet AI tool, developed by the Sydney-based Garvan Institute
Covid-19 virus protein triggers immune attack on healthy cells: Study

Health & LifestyleCovid-19 virus protein triggers immune attack on healthy cells: Study
New Delhi: Amid a fresh wave of Covid-19, Israeli researchers have discovered that a protein from the SARS-CoV-2 virus can cause the immune system to attack healthy cells mistakenly. The study, published in the journal Cell Reports, sheds light on how severe Covid complications may occur and suggests new ways to prevent immune-driven damage from
Global AI collaboration revolutionises personalised cancer treatment

Health & LifestyleGlobal AI collaboration revolutionises personalised cancer treatment
New Delhi: An international team of scientists has unveiled an artificial intelligence (AI) technique that securely analyses global cancer samples, paving the way for more personalised and privacy-protected cancer treatments. This innovative approach promises to accelerate personalised cancer treatment by enabling clinicians to match therapies to individual patients better, Xinhua news agency reported. The study
